Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives. Optimapharm’s key priorities are our people and consistently exceeding our client’s expectations.
With 26 strategically located offices across Europe, Optimapharm gives unrivalled access to Patients and Investigators worldwide.
In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years.
Companies Figures
• 510+ staff members
• Excellence in delivery and superior project performance with an investigator network of 1000+ active sites
• Close client relationship & high client retention rate of 85%
• Highly educated workforce & low staff turnover rate; less than 15%, across the organization
• Regional Cost-effective solutions
====
Full-service study delivery, Stand-alone service and Functional Service Provider are the 3 pillars Optimapharm offers to best respond to planned clinical development and efficiently resource clinical projects.
• Regulatory Affairs
• Medical Affairs
• Medical Writing
• Clinical Monitoring
• Project Management
• Data Management
• Biostatistics
• Safety and Vigilance
• Quality
• Translation Services
OPTIMAPHARM's offices:
- Austria
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Croatia
- Czech Republic
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Hungary
- Lithuania
- Republic of North Macedonia
- Moldova
- Poland
- Romania
- Serbia
- Slovenia
- Spain
- Sweden
- Switzerland
- The United Kingdom
- The United States of America
Industry
Pharmaceutical Manufacturing, Medical and pharmaceutical research, Research and testing, IT, Internet, R&D
HQ Location
Almeria Business Tower, 10th Floor
Ulica grada Vukovara 284
Zagreb, 10000, HR
Keywords
oncologymetabolic diseaseseurologypsychiatrycardiovascular diseasesimmunologyvanced therapiesrare diseasespulmonary diseaseshemato-oncology